tradingkey.logo
tradingkey.logo
Suchen

Treace Medical Concepts Inc

TMCI
Zur Watchlist hinzufügen
4.210USD
-0.020-0.47%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
272.75MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Treace Medical Concepts Inc Unternehmen

Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.

Treace Medical Concepts Inc Informationen

BörsenkürzelTMCI
Name des UnternehmensTreace Medical Concepts Inc
IPO-datumApr 23, 2021
CEOTreace (John T)
Anzahl der mitarbeiter477
WertpapierartOrdinary Share
GeschäftsjahresendeApr 23
Addresse100 Palmetto Park Place
StadtPONTE VEDRA
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl32081
Telefon19043735940
Websitehttps://www.treace.com/
BörsenkürzelTMCI
IPO-datumApr 23, 2021
CEOTreace (John T)

Führungskräfte von Treace Medical Concepts Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
546.36K
+5.49%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
200.76K
-96.89%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
161.06K
-69.82%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
73.65K
+40.73%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
68.65K
--
Mr. Aaron J. Berutti
Mr. Aaron J. Berutti
Senior Vice President - Sales
Senior Vice President - Sales
--
--
Ms. Jane E. Kiernan
Ms. Jane E. Kiernan
Independent Director
Independent Director
--
--
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Mark L. Hair
Mr. Mark L. Hair
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lynn Lewis
Ms. Lynn Lewis
Investor Relations
Investor Relations
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
546.36K
+5.49%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
200.76K
-96.89%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
161.06K
-69.82%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
73.65K
+40.73%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
68.65K
--
Mr. Aaron J. Berutti
Mr. Aaron J. Berutti
Senior Vice President - Sales
Senior Vice President - Sales
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Treace Medical Concepts Inc?

Die fünf größten Anteilseigner von Treace Medical Concepts Inc sind: Mr. John K. Bakewell

Wie viele Institutionen halten Anteile an Treace Medical Concepts Inc (TMCI)?

Mit Stand vom 2026Q1 halten 342 Institutionen Anteile an Treace Medical Concepts Inc, mit einem Gesamtmarktwert von etwa 37.97M, was 58.61% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -15683733.00 gestiegen.